Given that targeting ferroptosis is a potential strategy to enhance targeted or immunotherapy, it is not clear whether MISP is implicated in regulation of lung cancer immune microenvironment, which should be an interesting work in the future. This evidence concerns the gene MISP and lung carcinoma.